Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhea N Coler

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Vaccine|July 1, 2017
CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccinationAllison F Christiaansen, Upasna Gaur Dixit, Rhea N Coler, et al.
FEMS Immunology and Medical Microbiology|March 14, 2009
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisRhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of AdministrationSara E Maloney, Ian E Stewart, Brendan K Podell, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Comparative study on the virulence of mycobacteriophagesIlaria Rubino, Carlos A Guerrero-Bustamante, Melissa Harrison, et al.
Journal of Virology|May 21, 2025
Comparative study on the virulence of mycobacteriophagesIlaria Rubino, Carlos A Guerrero-Bustamante, Melissa Harrison, et al.
Vaccine|August 15, 2009
Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsionSusan L Baldwin, Narek Shaverdian, Yasuyuki Goto, et al.
Frontiers in Microbiology|September 12, 2022
Therapeutic efficacy against <i>Mycobacterium tuberculosis</i> using ID93 and liposomal adjuvant formulationsSusan L Baldwin, Valerie A Reese, Sasha E Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosisSylvie Bertholet, Gregory C Ireton, Maria Kahn, et al.
Vaccines|January 21, 2023
An RNA-Based Vaccine Platform for Use against <i>Mycobacterium tuberculosis</i>Sasha E Larsen, Jesse H Erasmus, Valerie A Reese, et al.
Vaccine|March 24, 2016
Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain KSeung Bin Cha, Woo Sik Kim, Jong-Seok Kim, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Vaccine|July 1, 2017
CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccinationAllison F Christiaansen, Upasna Gaur Dixit, Rhea N Coler, et al.
FEMS Immunology and Medical Microbiology|March 14, 2009
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisRhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of AdministrationSara E Maloney, Ian E Stewart, Brendan K Podell, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Comparative study on the virulence of mycobacteriophagesIlaria Rubino, Carlos A Guerrero-Bustamante, Melissa Harrison, et al.
Journal of Virology|May 21, 2025
Comparative study on the virulence of mycobacteriophagesIlaria Rubino, Carlos A Guerrero-Bustamante, Melissa Harrison, et al.
Vaccine|August 15, 2009
Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsionSusan L Baldwin, Narek Shaverdian, Yasuyuki Goto, et al.
Frontiers in Microbiology|September 12, 2022
Therapeutic efficacy against <i>Mycobacterium tuberculosis</i> using ID93 and liposomal adjuvant formulationsSusan L Baldwin, Valerie A Reese, Sasha E Larsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosisSylvie Bertholet, Gregory C Ireton, Maria Kahn, et al.
Vaccines|January 21, 2023
An RNA-Based Vaccine Platform for Use against <i>Mycobacterium tuberculosis</i>Sasha E Larsen, Jesse H Erasmus, Valerie A Reese, et al.
Vaccine|March 24, 2016
Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain KSeung Bin Cha, Woo Sik Kim, Jong-Seok Kim, et al.
Pageof 14